1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bispecific Antibody Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Fragment-Based 1.2.3 IgG-Based 1.3 Market by Application 1.3.1 Global Bispecific Antibody Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cancer 1.3.3 Haemophilia 1.3.4 Other Diseases 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Bispecific Antibody Drug Market Perspective (2016-2027) 2.2 Bispecific Antibody Drug Growth Trends by Regions 2.2.1 Bispecific Antibody Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Bispecific Antibody Drug Historic Market Share by Regions (2016-2021) 2.2.3 Bispecific Antibody Drug Forecasted Market Size by Regions (2022-2027) 2.3 Bispecific Antibody Drug Industry Dynamic 2.3.1 Bispecific Antibody Drug Market Trends 2.3.2 Bispecific Antibody Drug Market Drivers 2.3.3 Bispecific Antibody Drug Market Challenges 2.3.4 Bispecific Antibody Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Bispecific Antibody Drug Players by Revenue 3.1.1 Global Top Bispecific Antibody Drug Players by Revenue (2016-2021) 3.1.2 Global Bispecific Antibody Drug Revenue Market Share by Players (2016-2021) 3.2 Global Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Bispecific Antibody Drug Revenue 3.4 Global Bispecific Antibody Drug Market Concentration Ratio 3.4.1 Global Bispecific Antibody Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibody Drug Revenue in 2020 3.5 Bispecific Antibody Drug Key Players Head office and Area Served 3.6 Key Players Bispecific Antibody Drug Product Solution and Service 3.7 Date of Enter into Bispecific Antibody Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Bispecific Antibody Drug Breakdown Data by Type 4.1 Global Bispecific Antibody Drug Historic Market Size by Type (2016-2021) 4.2 Global Bispecific Antibody Drug Forecasted Market Size by Type (2022-2027) 5 Bispecific Antibody Drug Breakdown Data by Application 5.1 Global Bispecific Antibody Drug Historic Market Size by Application (2016-2021) 5.2 Global Bispecific Antibody Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Bispecific Antibody Drug Market Size (2016-2027) 6.2 North America Bispecific Antibody Drug Market Size by Type 6.2.1 North America Bispecific Antibody Drug Market Size by Type (2016-2021) 6.2.2 North America Bispecific Antibody Drug Market Size by Type (2022-2027) 6.2.3 North America Bispecific Antibody Drug Market Size by Type (2016-2027) 6.3 North America Bispecific Antibody Drug Market Size by Application 6.3.1 North America Bispecific Antibody Drug Market Size by Application (2016-2021) 6.3.2 North America Bispecific Antibody Drug Market Size by Application (2022-2027) 6.3.3 North America Bispecific Antibody Drug Market Size by Application (2016-2027) 6.4 North America Bispecific Antibody Drug Market Size by Country 6.4.1 North America Bispecific Antibody Drug Market Size by Country (2016-2021) 6.4.2 North America Bispecific Antibody Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Bispecific Antibody Drug Market Size (2016-2027) 7.2 Europe Bispecific Antibody Drug Market Size by Type 7.2.1 Europe Bispecific Antibody Drug Market Size by Type (2016-2021) 7.2.2 Europe Bispecific Antibody Drug Market Size by Type (2022-2027) 7.2.3 Europe Bispecific Antibody Drug Market Size by Type (2016-2027) 7.3 Europe Bispecific Antibody Drug Market Size by Application 7.3.1 Europe Bispecific Antibody Drug Market Size by Application (2016-2021) 7.3.2 Europe Bispecific Antibody Drug Market Size by Application (2022-2027) 7.3.3 Europe Bispecific Antibody Drug Market Size by Application (2016-2027) 7.4 Europe Bispecific Antibody Drug Market Size by Country 7.4.1 Europe Bispecific Antibody Drug Market Size by Country (2016-2021) 7.4.2 Europe Bispecific Antibody Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Bispecific Antibody Drug Market Size (2016-2027) 8.2 Asia-Pacific Bispecific Antibody Drug Market Size by Type 8.2.1 Asia-Pacific Bispecific Antibody Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Bispecific Antibody Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Bispecific Antibody Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Bispecific Antibody Drug Market Size by Application 8.3.1 Asia-Pacific Bispecific Antibody Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Bispecific Antibody Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Bispecific Antibody Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Bispecific Antibody Drug Market Size by Region 8.4.1 Asia-Pacific Bispecific Antibody Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Bispecific Antibody Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Bispecific Antibody Drug Market Size (2016-2027) 9.2 Latin America Bispecific Antibody Drug Market Size by Type 9.2.1 Latin America Bispecific Antibody Drug Market Size by Type (2016-2021) 9.2.2 Latin America Bispecific Antibody Drug Market Size by Type (2022-2027) 9.2.3 Latin America Bispecific Antibody Drug Market Size by Type (2016-2027) 9.3 Latin America Bispecific Antibody Drug Market Size by Application 9.3.1 Latin America Bispecific Antibody Drug Market Size by Application (2016-2021) 9.3.2 Latin America Bispecific Antibody Drug Market Size by Application (2022-2027) 9.3.3 Latin America Bispecific Antibody Drug Market Size by Application (2016-2027) 9.4 Latin America Bispecific Antibody Drug Market Size by Country 9.4.1 Latin America Bispecific Antibody Drug Market Size by Country (2016-2021) 9.4.2 Latin America Bispecific Antibody Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Bispecific Antibody Drug Market Size (2016-2027) 10.2 Middle East & Africa Bispecific Antibody Drug Market Size by Type 10.2.1 Middle East & Africa Bispecific Antibody Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Bispecific Antibody Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Bispecific Antibody Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Bispecific Antibody Drug Market Size by Application 10.3.1 Middle East & Africa Bispecific Antibody Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Bispecific Antibody Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Bispecific Antibody Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Bispecific Antibody Drug Market Size by Country 10.4.1 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Bispecific Antibody Drug Introduction 11.1.4 Roche Revenue in Bispecific Antibody Drug Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Bispecific Antibody Drug Introduction 11.2.4 Amgen Revenue in Bispecific Antibody Drug Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Bispecific Antibody Drug Introduction 11.3.4 Sanofi Revenue in Bispecific Antibody Drug Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Bispecific Antibody Drug Introduction 11.4.4 Pfizer Revenue in Bispecific Antibody Drug Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Bispecific Antibody Drug Introduction 11.5.4 Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 AstraZeneca 11.6.1 AstraZeneca Company Details 11.6.2 AstraZeneca Business Overview 11.6.3 AstraZeneca Bispecific Antibody Drug Introduction 11.6.4 AstraZeneca Revenue in Bispecific Antibody Drug Business (2016-2021) 11.6.5 AstraZeneca Recent Development 11.7 Abbvie 11.7.1 Abbvie Company Details 11.7.2 Abbvie Business Overview 11.7.3 Abbvie Bispecific Antibody Drug Introduction 11.7.4 Abbvie Revenue in Bispecific Antibody Drug Business (2016-2021) 11.7.5 Abbvie Recent Development 11.8 Lindis Biotech 11.8.1 Lindis Biotech Company Details 11.8.2 Lindis Biotech Business Overview 11.8.3 Lindis Biotech Bispecific Antibody Drug Introduction 11.8.4 Lindis Biotech Revenue in Bispecific Antibody Drug Business (2016-2021) 11.8.5 Lindis Biotech Recent Development 11.9 MacroGenics 11.9.1 MacroGenics Company Details 11.9.2 MacroGenics Business Overview 11.9.3 MacroGenics Bispecific Antibody Drug Introduction 11.9.4 MacroGenics Revenue in Bispecific Antibody Drug Business (2016-2021) 11.9.5 MacroGenics Recent Development 11.10 Genmab 11.10.1 Genmab Company Details 11.10.2 Genmab Business Overview 11.10.3 Genmab Bispecific Antibody Drug Introduction 11.10.4 Genmab Revenue in Bispecific Antibody Drug Business (2016-2021) 11.10.5 Genmab Recent Development 11.11 Immunocore Limited 11.11.1 Immunocore Limited Company Details 11.11.2 Immunocore Limited Business Overview 11.11.3 Immunocore Limited Bispecific Antibody Drug Introduction 11.11.4 Immunocore Limited Revenue in Bispecific Antibody Drug Business (2016-2021) 11.11.5 Immunocore Limited Recent Development 11.12 Xencor 11.12.1 Xencor Company Details 11.12.2 Xencor Business Overview 11.12.3 Xencor Bispecific Antibody Drug Introduction 11.12.4 Xencor Revenue in Bispecific Antibody Drug Business (2016-2021) 11.12.5 Xencor Recent Development 11.13 Merck 11.13.1 Merck Company Details 11.13.2 Merck Business Overview 11.13.3 Merck Bispecific Antibody Drug Introduction 11.13.4 Merck Revenue in Bispecific Antibody Drug Business (2016-2021) 11.13.5 Merck Recent Development 11.14 Affimed 11.14.1 Affimed Company Details 11.14.2 Affimed Business Overview 11.14.3 Affimed Bispecific Antibody Drug Introduction 11.14.4 Affimed Revenue in Bispecific Antibody Drug Business (2016-2021) 11.14.5 Affimed Recent Development 11.15 Alphamab 11.15.1 Alphamab Company Details 11.15.2 Alphamab Business Overview 11.15.3 Alphamab Bispecific Antibody Drug Introduction 11.15.4 Alphamab Revenue in Bispecific Antibody Drug Business (2016-2021) 11.15.5 Alphamab Recent Development 11.16 Akeso 11.16.1 Akeso Company Details 11.16.2 Akeso Business Overview 11.16.3 Akeso Bispecific Antibody Drug Introduction 11.16.4 Akeso Revenue in Bispecific Antibody Drug Business (2016-2021) 11.16.5 Akeso Recent Development 11.17 BeiGene 11.17.1 BeiGene Company Details 11.17.2 BeiGene Business Overview 11.17.3 BeiGene Bispecific Antibody Drug Introduction 11.17.4 BeiGene Revenue in Bispecific Antibody Drug Business (2016-2021) 11.17.5 BeiGene Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Bispecific Antibody Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Fragment-Based Table 3. Key Players of IgG-Based Table 4. Global Bispecific Antibody Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Bispecific Antibody Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Bispecific Antibody Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Bispecific Antibody Drug Market Share by Regions (2016-2021) Table 8. Global Bispecific Antibody Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Bispecific Antibody Drug Market Share by Regions (2022-2027) Table 10. Bispecific Antibody Drug Market Trends Table 11. Bispecific Antibody Drug Market Drivers Table 12. Bispecific Antibody Drug Market Challenges Table 13. Bispecific Antibody Drug Market Restraints Table 14. Global Bispecific Antibody Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Bispecific Antibody Drug Market Share by Players (2016-2021) Table 16. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Antibody Drug as of 2020) Table 17. Ranking of Global Top Bispecific Antibody Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Bispecific Antibody Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Bispecific Antibody Drug Product Solution and Service Table 21. Date of Enter into Bispecific Antibody Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Bispecific Antibody Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Bispecific Antibody Drug Revenue Market Share by Type (2016-2021) Table 25. Global Bispecific Antibody Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Bispecific Antibody Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Bispecific Antibody Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Bispecific Antibody Drug Revenue Market Share by Application (2016-2021) Table 29. Global Bispecific Antibody Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Bispecific Antibody Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Bispecific Antibody Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Bispecific Antibody Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Bispecific Antibody Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Bispecific Antibody Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Bispecific Antibody Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Bispecific Antibody Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Bispecific Antibody Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Bispecific Antibody Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Bispecific Antibody Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Bispecific Antibody Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Bispecific Antibody Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Bispecific Antibody Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Bispecific Antibody Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Bispecific Antibody Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Bispecific Antibody Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Bispecific Antibody Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Bispecific Antibody Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Bispecific Antibody Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Bispecific Antibody Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Bispecific Antibody Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Bispecific Antibody Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Bispecific Antibody Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Bispecific Antibody Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Bispecific Antibody Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Bispecific Antibody Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Bispecific Antibody Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Bispecific Antibody Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Bispecific Antibody Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. Roche Company Details Table 62. Roche Business Overview Table 63. Roche Bispecific Antibody Drug Product Table 64. Roche Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 65. Roche Recent Development Table 66. Amgen Company Details Table 67. Amgen Business Overview Table 68. Amgen Bispecific Antibody Drug Product Table 69. Amgen Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 70. Amgen Recent Development Table 71. Sanofi Company Details Table 72. Sanofi Business Overview Table 73. Sanofi Bispecific Antibody Drug Product Table 74. Sanofi Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 75. Sanofi Recent Development Table 76. Pfizer Company Details Table 77. Pfizer Business Overview Table 78. Pfizer Bispecific Antibody Drug Product Table 79. Pfizer Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 80. Pfizer Recent Development Table 81. Johnson & Johnson Company Details Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Bispecific Antibody Drug Product Table 84. Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 85. Johnson & Johnson Recent Development Table 86. AstraZeneca Company Details Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Bispecific Antibody Drug Product Table 89. AstraZeneca Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 90. AstraZeneca Recent Development Table 91. Abbvie Company Details Table 92. Abbvie Business Overview Table 93. Abbvie Bispecific Antibody Drug Product Table 94. Abbvie Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 95. Abbvie Recent Development Table 96. Lindis Biotech Company Details Table 97. Lindis Biotech Business Overview Table 98. Lindis Biotech Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 99. Lindis Biotech Recent Development Table 100. MacroGenics Company Details Table 101. MacroGenics Business Overview Table 102. MacroGenics Bispecific Antibody Drug Product Table 103. MacroGenics Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 104. MacroGenics Recent Development Table 105. Genmab Company Details Table 106. Genmab Business Overview Table 107. Genmab Bispecific Antibody Drug Product Table 108. Genmab Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 109. Genmab Recent Development Table 110. Immunocore Limited Company Details Table 111. Immunocore Limited Business Overview Table 112. Immunocore Limited Bispecific Antibody Drug Product Table 113. Immunocore Limited Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 114. Immunocore Limited Recent Development Table 115. Xencor Company Details Table 116. Xencor Business Overview Table 117. Xencor Bispecific Antibody Drug Product Table 118. Xencor Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 119. Xencor Recent Development Table 120. Merck Company Details Table 121. Merck Business Overview Table 122. Merck Bispecific Antibody Drug Product Table 123. Merck Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 124. Merck Recent Development Table 125. Affimed Company Details Table 126. Affimed Business Overview Table 127. Affimed Bispecific Antibody Drug Product Table 128. Affimed Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 129. Affimed Recent Development Table 130. Alphamab Company Details Table 131. Alphamab Business Overview Table 132. Alphamab Bispecific Antibody Drug Product Table 133. Alphamab Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 134. Alphamab Recent Development Table 135. Akeso Company Details Table 136. Akeso Business Overview Table 137. Akeso Bispecific Antibody Drug Product Table 138. Akeso Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 139. Akeso Recent Development Table 140. BeiGene Company Details Table 141. BeiGene Business Overview Table 142. BeiGene Bispecific Antibody Drug Product Table 143. BeiGene Revenue in Bispecific Antibody Drug Business (2016-2021) & (US$ Million) Table 144. BeiGene Recent Development Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Bispecific Antibody Drug Market Share by Type: 2020 VS 2027 Figure 2. Fragment-Based Features Figure 3. IgG-Based Features Figure 4. Global Bispecific Antibody Drug Market Share by Application: 2020 VS 2027 Figure 5. Cancer Case Studies Figure 6. Haemophilia Case Studies Figure 7. Other Diseases Case Studies Figure 8. Bispecific Antibody Drug Report Years Considered Figure 9. Global Bispecific Antibody Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Bispecific Antibody Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Bispecific Antibody Drug Market Share by Regions: 2020 VS 2027 Figure 12. Global Bispecific Antibody Drug Market Share by Regions (2022-2027) Figure 13. Global Bispecific Antibody Drug Market Share by Players in 2020 Figure 14. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Antibody Drug as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Bispecific Antibody Drug Revenue in 2020 Figure 16. Global Bispecific Antibody Drug Revenue Market Share by Type (2016-2021) Figure 17. Global Bispecific Antibody Drug Revenue Market Share by Type (2022-2027) Figure 18. North America Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Bispecific Antibody Drug Market Share by Type (2016-2027) Figure 20. North America Bispecific Antibody Drug Market Share by Application (2016-2027) Figure 21. North America Bispecific Antibody Drug Market Share by Country (2016-2027) Figure 22. United States Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Bispecific Antibody Drug Market Share by Type (2016-2027) Figure 26. Europe Bispecific Antibody Drug Market Share by Application (2016-2027) Figure 27. Europe Bispecific Antibody Drug Market Share by Country (2016-2027) Figure 28. Germany Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Bispecific Antibody Drug Market Share by Type (2016-2027) Figure 36. Asia-Pacific Bispecific Antibody Drug Market Share by Application (2016-2027) Figure 37. Asia-Pacific Bispecific Antibody Drug Market Share by Region (2016-2027) Figure 38. China Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Bispecific Antibody Drug Market Share by Type (2016-2027) Figure 46. Latin America Bispecific Antibody Drug Market Share by Application (2016-2027) Figure 47. Latin America Bispecific Antibody Drug Market Share by Country (2016-2027) Figure 48. Mexico Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Bispecific Antibody Drug Market Share by Type (2016-2027) Figure 52. Middle East & Africa Bispecific Antibody Drug Market Share by Application (2016-2027) Figure 53. Middle East & Africa Bispecific Antibody Drug Market Share by Country (2016-2027) Figure 54. Turkey Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Bispecific Antibody Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Roche Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 58. Amgen Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 59. Sanofi Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 60. Pfizer Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 61. Johnson & Johnson Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 62. AstraZeneca Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 63. Abbvie Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 64. Lindis Biotech Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 65. MacroGenics Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 66. Genmab Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 67. Immunocore Limited Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 68. Xencor Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 69. Merck Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 70. Affimed Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 71. Alphamab Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 72. Akeso Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 73. BeiGene Revenue Growth Rate in Bispecific Antibody Drug Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Roche Amgen Sanofi Pfizer Johnson & Johnson AstraZeneca Abbvie Lindis Biotech MacroGenics Genmab Immunocore Limited Xencor Merck Affimed Alphamab Akeso BeiGene